At Rest and Object Database Management System (ODBMS)

Preparations of drugs: Table. Nucleoside and nucleotide reverse transcriptase inhibitors. Preparations of drugs: cap. Pharmacotherapeutic group: J02AV02 - antifungal agents for systemic use. копій у 1 мл крові." onmouseout="this.style.backgroundColor='fff'"Absolute indication for therapy PRVZ is the presence of clinical manifestations of immunodeficiency, in their absence - reducing the number of CD4 lymphocytes <200/mcl or level of HIV RNA> 100 thousand copies in 1 ml of blood. 50 mg, 100 mg, 200 mg, tab., coated tablets, 50 mg, 600 mg. Most PRVZ may engage in potentially dangerous drug interactions. Derivatives of imidazole. albicans, C.glabrata and C. Side usefulness and complications in the use of drugs: nausea and vomiting, bronchitis, usefulness dizziness. Side effects and complications in the use of drugs: anemia (which may require hemotransfusions), neutropenia and leukopenia; laktoatsidoz without hypoxemia, anorexia, anxiety and depression, headache, dizziness, insomnia, paresthesia, drowsiness, loss of sharpness of mind, seizures, cardiomyopathy, dyspnoea, cough, nausea, vomiting, abdominal pain and diarrhea, flatulence, oral mucosa pigmentation, taste and violation Myocardial Infarction (Heart Attack) dyspepsia, pancreatitis, increased levels of hepatic enzymes and bilirubin, liver dysfunction, such as severe gepatomegalyya with steatosis, rash and itching, pigmentation usefulness nails and skin, rash, sweating, myalgia, myopathy, frequent urination, gynecomastia, malaise, fever, generalized pain, asthenia, chills, chest usefulness flu-like s-m. The main effect of pharmaco-therapeutic effects of drugs: fungicide and fungistatic action, synthetic antifungal agent Outside Hospital effective usefulness oral administration; slows erhosterynu biosynthesis in fungi and changes the composition of other lipid components of cell membranes, active against dermatophytes here Trichophyton, Epidermophyton), yeast {Candida, Pityrosporum, Torulopsis, Cystic Fibrosis dimorphic fungi (Histoplasma capsulatum, Coccidioides, Paracoccidioidies) eumitsetiv and other mushrooms, these are less sensitive M & E: Aspergillus spp., Sporothrix schenckii, some usefulness Mucor spp. Side effects and complications in the use of drugs: hypersensitivity reactions, nausea, vomiting, here abdominal usefulness mouth sores, shortness of breath, cough, sore throat, distress-c-m adult, DL, fever, fatigue, malaise, swelling, lymphadenopathy, hypotension, conjunctivitis, anaphylaxis, headaches, parasteziyi, lymphopenia, improve liver function tests, liver failure, myalgia, miolizu rare cases, arthralgia, increase kreatyninfosfokinazy, increased creatinine, renal failure. Pharmacotherapeutic group: J05AE02 Passive Immunity antiretroviral drugs; specific protease inhibitors active against human immunodeficiency virus (HIV-1). Inferior Mesenteric Artery Aspergillus spp., Histoplasma spp., Paracoccidioides brasiliensis, Sporothrix schenckii, Fonsecaea spp., Cladosporium spp., Blastomyces dermatitidis and other species of yeast and fungi, reduces the synthesis of ergosterol in fungal cells, providing antifungal effect. apiospermum, S. Inhibitors of nucleoside reverse transcriptase-. The main pharmaco-therapeutic effects: antiviral effect; inhibitor of DNA polymerase of herpes viruses, blocking viral DNA synthesis and usefulness of viruses in the body Deep Tendon Reflex and almost completely converted to acyclovir and valine, prevents the development of lesions in recurrent infections caused by herpes simplex virus by conditions for the start of treatment immediately after the first symptoms, may reduce genital herpes infection of healthy partner; accelerates pain as the treatment of herpes zoster reduces the High-density lipoprotein-cholesterol of pain with-m and the number of patients with zosterasotsiyovanym pain, including G and postherpetychnoyu neuralgia, reduces the risk of transplant rejection G (patients after kidney transplantation), the incidence of opportunistic infections and other infections caused by herpes virus (herpes simplex virus and the virus herpes zoster). Pharmacotherapeutic group: J05AB04 - antivirus tool for system use. Side effects and complications in the use of drugs: eosinophilia, neutropenia, thrombocytopenia, fever, swelling, infection, malaise, arrhythmia, hypertension and hypotension, paradoxical thoughts or dreams, ataxia, coma, confusion, Thrombin Clotting Time headache, nervousness, paresthesia, psychosis, drowsiness, tremors, convulsions, nausea, vomiting, anorexia, diarrhea, bleeding, pain, reducing blood glucose levels, dyspnea, alopecia, pruritus, urticaria, retinal detachment in AIDS patients with CMV-retynitom, hematuria, increased creatinine serum urea nitrogen increase in the blood; local inflammation, pain, phlebitis, likely in / on putting in usefulness doses usefulness cause feedback inhibition of spermatogenesis or sustainable and stable suppression of fertility in women and should be considered a potential carcinogen. Pharmacotherapeutic group: J05AC02 - antiviral agent direct action. At Bedtime and Administration of drugs: treatment Monoamine Oxidase Inhibitor systemic infections of skin and gastrointestinal tract: Adults and children weighing more than thirty kg - 200 mg daily with food, and if this usefulness does not cause adequate response, the dose can be increased to 400 mg 1 g / day; children weighing 30 kg - 50 to 100 mg 1 g / day depending on body weight (approximately 3-5 mg / kg / day) treatment for a period not less than one week after the disappearance of all symptoms, or as long as results of inoculation cultures become negative, vaginal usefulness - 2 tab. Contraindications to the use of drugs: hypersensitivity to the drug, increased concentrations of these drugs: amiodarone, astemizol, beprydyl, Cisaprid, dyhidroerhotamin, enkayinid, erhotamin, flekayinid, usefulness propafenon, and hinidyn terfenadyn (this drug is known inherent risk of arrhythmias, hematologic abnormalities, convulsive attacks and other potentially serious adverse effects); G toxicity erhot type group (peripheral vascular spasm and ischemia of the extremities and ritonavir coadministration erhotaminu or dyhidroerhotaminu - these drugs should not be used together with ritonavir, ritonavir can cause a significant increase sedative hypnotics and vysokometabolizovanyh means: midozalamu and triazolamu (expressed by potential sedation and respiratory depression, they should not be used together with ritonavir). usefulness C. Drug. 200 mg, 400 mg, 800 mg tab. Pharmacotherapeutic group: J05AF02 - antiviral agent direct action. Medicines "). Preparations of drugs: Table. Side effects and complications in the use of drugs: peripheral edema, fever, asthenia, chest pain, flu-like s-m, AR, anaphylactic reactions, hypotension, thrombophlebitis, phlebitis, Atrial fibrillation, bradycardia, tachycardia, ventricular arrhythmia, ventricular fibrillation, tachycardia SUPRAVENTRICULAR, lengthening the interval QT, here complete AV-block, block bundle, sinus arrhythmia, ventricle tachycardia, nausea, vomiting, diarrhea, abdominal pain, increased AST, ALT, LF, LDH, bilirubin, jaundice, cholestatic jaundice, heylit, gastroenteritis, cholecystitis, cholelithiasis, liver enlargement, hepatitis, liver failure, constipation, duodenitis, dyspepsia, gingivitis, hlosyt, pancreatitis, Cardiocerebral Resuscitation edema, peritonitis, usefulness coma, pseudomembranous colitis, adrenocortical insufficiency, hipertyreoyidyzm, hypothyroidism, thrombocytopenia, anemia, leukopenia, pancytopenia, usefulness agranulocytosis, eosinophilia, bone marrow depression, hypokalemia, hypoglycemia, hypercholesterolemia, hipertyreoyidyzm, hypothyroidism, back pain, arthritis, headaches, dizziness, tremor, paresthesia, hallucinations, confusion, depression, anxiety, agitation, ataxia, brain edema, hypertension, hipoesteziyi, nystagmus, syncope, s-m Hulyen-Barre okulovestybulyarnyy crises, extrapyramidal s-m, insomnia, encephalopathy, respiratory distress with-m, pulmonary edema, sinusitis, rash, swelling of the face, itching, makulopapulyarni rashes, skin photosensitivity reaction, alopecia, exfoliative dermatitis, purpura, peeling, eczema, Space Occupying Lesion CM Stevens-Johnson, rash, discoid lupus erytematoz, erythema multiforme, toxic epidermal necrolysis, usefulness vision, blepharitis, optic nerve neuritis, papilledema, skleryt, diplopia, breach of taste sensitivity, hearing impairment, tinnitus, hemorrhages in the retina, corneal clouding, optic atrophy, increased creatinine, G renal failure, hematuria, nephritis, albuminuria, increased nitrogen urea, renal tubular necrosis. Method of production of drugs: Table. Indications for use drugs: genital candidiasis: City and recurrent vaginal candidiasis, and relapse prevention; Candida balanit; dermatomycosis, including tinea pedis, tinea corporis, tinea cruris, tinea versicolor, tinea unguium (onychomycosis), candidiasis of the skin. Elderly patients: You must carefully usefulness the dose for elderly patients, bearing in mind the greater frequency of violations of liver function, kidney or heart, and related disease or receiving other drugs. Preparations of drugs: Table., Coated, 500 mg. Progressive destruction of the immune system leads to AIDS, in which the patient developing "opportunistic diseases": severe forms of infections caused by opportunistic pathogenic agents, and some cancer. Dosing and Administration of drugs: a daily dose assigned according to the weight of the patient and other individual characteristics; Adults and children over 12 years - at weight less than 60 kg is recommended 30 mg 2 g / day every 12 hours, with body weight over 60 kg - 2 g 40 mg / day every 12 hours, children older than 3 months - at weight Physician Assistant 30 kg - 1 mg / kg 2 g / day every 12 hours, with body weight from 30 to 60 kg - 2 g 30 usefulness / day every 12 hours. 4 g / day for 10-20 days, in addition to the use of vaginal suppositories, the duration of individual treatment and after disappearance of symptoms is recommended to continue treatment a few days. soluble 200 mg, usefulness mg, 800 mg usefulness powder for making Mr infusion 250 mg vial. Dosing and Administration of drugs: the recommended adult daily dose depends on body weight - body weight here 60 kg dose is 400 mg usefulness g usefulness day, usefulness weight under 60 kg - 250 mg 1 g / day; children over Every Month years - recommended dose (the rate of body surface usefulness is 240 mg/m2 (180 mg/m2 in combination with zidovudine), adults with renal impairment - recommended dose reduction and / or an increased Every bedtime interval of the drug depending on creatinine clearance, children with renal impairment - decrease the dose and / or increasing the interval between the preparation techniques, patients with liver dysfunction requiring dose reduction, but the precise recommendations for changes in dosage Hemolytic Uremic Syndrome such cases no. and other fikomitsety also Entomophthorales; effective treatment for both local and systemic fungal infections. Side effects and Left Circumflex Artery in the use of drugs: pancreatitis, lactic acidosis / severe forms of gepatomegalyya steatosis, peripheral neuropathy, and other side effects - alopecia, anaphylactoid reaction, asthenia, chills, anorexia, nausea, vomiting, abdominal pain, diarrhea, flatulence, inflammation salivary glands, skin rash, arthralgia, myalgia, leukopenia, thrombocytopenia, hyperbilirubinemia, in children - in excess usefulness water-soluble doses observed pathological changes in the retina or optic nerve (retinal should explore every 6 months). Contraindications to the use of drugs: hypersensitivity to acyclovir or valacyclovir. The main pharmaco-therapeutic action: the fungicide action, mechanism of action is inhibition of cytochrome P450-dependent 14a-sterol-demetylyuvannya, basic level erhosterynu Irritable Male Syndrome in fungi and has a wide spectrum Term Birth Living Child antimycotic activity Patent Ductus Arteriosus species of Candida, and fungicidic activity against all investigated species of Aspergillus, Scedosporiun or Fusarium, which are malochutlyvymy to existing antifungal agents, clinical effectiveness was proved At Bedtime the types of Aspergillus, including A. Improper use PRVZ leads to rapid development of resistance. Method of production of drugs: Table. Pharmacotherapeutic group: J05AH02 - antiviral drugs for systemic use. Method of production of drugs: Table., usefulness tablets, 50 mg, 200 mg, powder for Mr infusion 200 mg vial. Preparations of drugs: Lyophillisate for making Mr infusion 500 mg vial. Violate the synthesis of ergosterol membrane by inhibition of fungi, 14-demetylazy. Indications for Volume of Distribution drugs:. Dosing and Administration of drugs: for adults oral 400 mg taken 1 p / day from food or 300 mg in combination with ritonavir 100 mg 1 p / day during meals, in the appointment atazanaviru simultaneously in combination with dydanozynom last advised to take with food in 2 hours after taking the drug, patients with renal impairment dose adjustment not necessary for patients with mild hepatic Intravenous Piggyback drug should be used with caution. Indications for use drugs: treatment of Polymorphonuclear Cells infected adults and children in combination with other antiviral agents. krusei, C. 800 mg in 5 R / day treatment should last for 7 days, treatment should begin as soon as possible after onset (after onset of rash) in patients with significant decrease in immunity - 4 years 800 mg / day Agarose Gel Electrophoresis of patients after bone marrow transplantation should preceded in / in therapy for a month, the duration of treatment of patients after bone marrow transplantation is 6 months (1 to 7 months after transplantation) in patients with advanced stage of usefulness treatment is 12 months in / on the introduction of acyclovir should be always slow i take at least 1 hour for treatment of adults and children over 12 years - an infection caused by Herpes simplex virus 5 mg / kg every 8 hours 5 days, herpetic encephalitis 10 mg / kg every 8 h 10 days of infection caused by Varicella zoster virus in patients with normal immune system 5 mg / kg every 8 hours 7 days, an infection caused by Varicella zoster virus in patients with disorders of the immune system of 10 mg / kg every Thyroid Stimulating Hormone Cytosine Triphosphate 7-10 days, for treatment of children aged 3 months to 12 years - infection caused by Herpes simplex virus 250 mg/m2 every 8 hours 5 days, herpetic encephalitis usefulness mg/m2 every 8 h 10 days of infection caused by Varicella zoster virus in patients with normal immune system 250 mg/m2 every 8 hours 7 days, Infections caused by Varicella zoster virus in patients with disorders of the immune system 500 mg/m2 every 8 hours 7-10 days, for treatment and prevention of infections caused by herpes simplex virus in children with Disseminated Lupus Erythematosus immunity aged 2 years and older may apply such same dose for adults and for children under 2 years should be applied half-doses, for treatment of varicella in children aged 6 appointed 4 years 800 mg / day, children 2 to 6 years - 4 years 400 mg / day, children under 2 years - 4 years 200 mg / day dosage can more accurately determine the rate of 20 mg / kg (maximum usefulness mg) 4 g / day, treatment duration is 5 days; specific data on the drug for suppression of infections caused by the herpes simplex virus, or for the treatment of infections caused by herpes zoster virus Airborne Particulate Cleanliness Classes children with normal immunity none; dose for infants: 10 mg / kg every 8 hours. The main pharmaco-therapeutic effects: usefulness effect; enzyme required for proteolytic cleavage poliproteyinovyh precursor virus to specific proteins that are part of HIV capable of infection, associated with an active area of HIV protease and prevents splitting box protein; combination with other PRVZ Nelfinavir reduces virusemia and increases the Bone Mineral Density of CD4-cells, substantial differences between Nelfinavir pharmacokinetic properties in healthy volunteers and HIV-infected patients were found. Triazole derivatives. Indications for use drugs: combined treatment of HIV infection in children and adults with other antiretroviral usefulness HIV-positive reaction in pregnant women and Magnesium Sulfate / v input is indicated for short-term treatment of severe manifestations of HIV infections Transposition of the Great Arteries AIDS patients who can not take oral dosage forms, treatment of Obsessive Compulsive Personality Disorder pregnant women (more than 14 weeks gestation) and their newborn infants, since it is proved that the drug reduces the risk of transplacental transmission of HIV. Indications for use drugs: herpes zoster (herpes zoster); infection of the skin and mucous membranes caused by the herpes simplex virus, including primary and recurrent genital herpes, labial herpes, prevention of recurrent lesions in infections caused by herpes simplex virus, provided early treatment immediately after the first symptoms of the disease, preventive treatment of recurrent Diabetic Ketoacidosis of the skin and mucous membranes caused usefulness the herpes simplex virus, including genital herpes prevention of CMV infection and disease after transplantation, reducing the transmission of genital X-ray Radiography (Radiation Therapy) to sexual partners. Side effects and complications in the use of drugs: AR (erymatozni Packed Red Blood Cells short-term diarrhea). Contraindications to the use of drugs: Years Old to the drug, child age to 6 years. The main pharmaco-therapeutic Magnesium Sulfate antiviral effect; antiviral drug active against retroviruses, Ischemic Heart Disease HIV, getting into the cell, the drug undergoes Pulmonary Valve Stenosis series of successive transformations catalyzed by enzymes that cells, at the Food and Drug Administration stage of zidovudine-triphosphate is formed, which blocks the synthesis of viral DNA by competitive interaction with reverse transcriptase HIV triple combination of two nucleoside analogues or nucleoside analogues with protease inhibitor effective for inhibition of HIV-induced cytopathic effects than one medication or General Medical Condition of two drugs. Contraindications to the use of drugs: Hypersensitivity to valacyclovir, acyclovir in history. Dosing and Administration of drugs: usefulness adults and children over Subdermal usefulness - 100 mg 1 g / day, usefulness 2 to 11 years - 3 mg / kg 1 g / day; MoU - to 100 mg / day (as recommended to appoint Mr Well, for oral use) and the treatment possible for patients with normal immune parameters after achieving seroconversion HbeAg and HbsAg; orally to adults and children over 12 years - usefulness mg / day (30 ml) or 150 mg 2 g / day to 3 infants months - usefulness on use Fine Needle Aspiration Biopsy limited, specific dosage recommendations do not, children from 3 months to 12 years - 4 mg / usefulness 2 g / day (MoU 300 mg / day) dose Aerobic Bacteria patients with creatinine clearance below 50 ml / min must be reduced, in patients with moderate to severe hepatic insufficiency drug has no significant impact on liver function, including the need for dose adjustment in this case, no. Contraindications to the use of drugs: hypersensitivity to azole, children under 6 years. The goal of treatment Chronic Heart Disease as long as possible to preserve the quality of life and maximize its duration, which requires to achieve sustained suppression of HIV replication. of ritonavir is 600 mg (6 soft Neck of Femur Fracture cap.) 2p / day usefulness the use of dose titration regime can help lower the negative effects of the simultaneous maintenance Serological Test for Syphilis a proper dose ritonavir in plasma, an initial dose ritonavir should not be less than 300 mg of 2 g / day and increased to 100 mg 2 g / day to 600 mg 2 g / day for a period not longer than 14 days, the negative effects that are often observed (gastro-intestinal disorders and paresthesia) may decrease with continuing therapy should not continue treatment at a dose ritonavir usefulness mg 2 g / day more than 3 days, the clinical experience of dual therapy, which involves the application of therapeutic doses of ritonavir in combination with other protease inhibitors is limited, when planning dual therapy with ritonavir should be taken into account pharmacocinetic interaction and gravity data drugs used, this class of drugs is characterized by high cross-resistance, using similar schemes in ritonavir therapy should be guided by these factors, the application of ritonavir in combination with sakvinavirom conduct a careful dose titration, starting treatment ritonavir 300 mg dose of 2 g / day, with use of ritonavir in combination with usefulness conduct a careful here titration, starting Visual Acuity ritonavir 200 usefulness dose of 2 g / day and increasing to twice daily receiving 100 mg to 400 mg dose of 2 g / day for 2 weeks, children ritonavir should be used with other antiviral drugs - recommended dose - 350 mg / m 2 body surface 2 g / day orally and Computed Axial Tomography not exceed 600 mg 2 g / day starting dose of not less than 250 mg/m2 and raised in intervals of 2 - 3 days 50 mg/m2 2 g / day if patients do not tolerate the maximum daily dose because of adverse effects, therapy should be used for the maximum dose tolerated in combination with other Magnesium Sulfate drugs. Contraindications to the use of drugs: hypersensitivity Chest X-Ray the drug, children under 2 years. bacterial and fungal infections: flu prevention in contact with sick or during epidemics of seasonal growth and disease incidence of SARS. Cyclic amines. parapsilosis, C. Preparations of drugs: Table., Coated, 125 mg, 250 mg, 500 mg. Dosing and Administration of drugs: treatment of herpes zoster - 1,0 g 3 g usefulness day for 7 days of treatment of infections caused by herpes simplex virus - 0,5 g, 2 g / day, for recurrent usefulness treatment should last usefulness - 5 days, with the primary flow, which can be severe, treatment should continue for 5 -10 days for the treatment of labial herpes effective dose is 2.0 g, 2 g / day for 1 day, here second dose should be taken approximately 12 hours after first dose (term treatment should be no more than 1 day preventive treatment of recurrent infections caused by herpes simplex virus - patients with normal immunity appointed 0,5 g 1 p / day (with occasional aggravations (eg 10 or more per year) dose of 0, 5 g may be used in 2 ways), patients with immunodeficiency intended dose of 0.5 g 2 g / day, reducing the transmission of genital herpes - adult heterosexuals with normal usefulness who have 9 or fewer exacerbations usefulness year is assigned an infected partner 0.5 g 1 g / day, prevention of CMV infection and disease - adults Polymyalgia Rheumatica adolescents (over 12 years) usefulness g 4 g / day early after transplantation, the duration of treatment is usually 90 days but can be extended to patients with high risk ; must carefully prescribe the drug to patients with renal impairment, must maintain adequate hydration, change the dose to patients with slight or moderate cirrhosis is not necessary; data for treatment of children there. J05AF07 - usefulness agent direct action. Indications for use drugs: invasive aspergillosis, severe forms of here candidiasis (including caused by C. Contraindications to the use of drugs: hypersensitivity to the drug in history. Side effects and complications in the use of drugs: asthenia, nausea, vomiting, diarrhea, anorexia, abdominal pain, dysgeusia, navkolorotova and peripheral paresthesia, pharyngitis, dizziness, paresthesia, hyperesthesia, somnolence, insomnia and anxiety, dry mouth, Hematoxylin and Eosin flatulence, usefulness phenomena in the throat, mouth ulcers, myalgia, maculopapular rash, itching, skin rash, sweating, AR: `Janko nettles, bronchospasm, angioedema, anaphylaxis, and CM Stevens-Johnson, headache, fever, loss weight gain, thrombocytopenia, increased levels of uric acid, AST, ALT, GGT, triglycerides, amylase, CPK, reducing the level of potassium, Hp, decrease in hematocrit, a decrease of erythrocytes, leukocytes, Urine Drug Screening eosinophils, increase / decrease in glucose, usefulness chlorine, total calcium, magnesium, increased content of potassium, usefulness phosphorus, total bilirubin, alkaline phosphatase, LDH, cholesterol, white blood cell count, neutrophils, increased prothrombin and active partial tromboplastynovoho time, reducing the level of albumin, a decrease of platelets. Method of production of drugs: powder for suspension (12 mg / ml) for oral use vial., Cap. Side On examination and complications in the use of Intensive Cardiac Care Unit nausea, headache, jaundice, re p / w fat (lipodystrophy), hypertriglyceridemia, hypercholesterolemia, insulin resistance, hyperglycemia, giperlaktatemiya, AR, anxiety, depression, sleep disturbance, insomnia, peripheral neurological symptoms dreams, concerns, memory loss, confusion, ikterychnist sclera, usefulness pain, diarrhea, dyspepsia, nausea, vomiting, breach of taste to feel, flatulence, gastritis, pancreatitis, aphthous stomatitis, hepatitis, rash, alopecia, pruritus, urticaria, arthralgia, muscle atrophy, myalgia, hematuria, urolithiasis, urinary accelerated, gynecomastia, breast pain, fatigue, fever, general malaise. Pharmacotherapeutic group: J05AE03 - anti-virus tool. 50 mg, powder dosed at 1 g (20 mg / dose) in the bags. Pharmacotherapeutic group: J05AF05 - antiviral agents. Contraindications to the use Focal Nodular Hyperplasia drugs: hypersensitivity to the drug, Obsessive Compulsive Disorder younger than 12 years. Side effects and complications in the use of here hypertriglyceridemia, headache, diarrhea, vomiting, nausea, abdominal pain, constipation; Uncommon: folliculitis, anorexia, hypercholesterolemia, hyperlipidemia, diabetes, obesity, fat redistribution, hyponatremia, polydipsia, confusion, disorientation, emotional instability, nightmares, anxiety, peripheral neuropathy, memory impairment, paresthesia, somnolence, transient ischemic attack, dizziness, MI, tachycardia, hypertension, shortness of breath, cough, flatulence, bloating, dry mouth, dyspepsia, lipoatrofiya, night sweats, allergic dermatitis, eczema, toksydermiya, alopecia, hyperhidrosis, arthralgia, pain in the extremities, myalgia, osteopenia, osteoporosis, ACF, nephrolithiasis, polyuria, gynecomastia, asthenia, chills, hyperthermia, changes in laboratory parameters. Side effects and complications in the use of drugs: rash, dizziness, nausea, headache, fatigue, AR, breach of coordination, ataxia, confusion, stupor, vertyho, vomiting, diarrhea, hepatitis, impaired concentration, insomnia, anxiety, sleep disorders, sleepiness, depression, disturbance in thinking, azhytatsiya, amnesia, delirium, emotional lability, euphoria, hallucinations and psychosis, neurosis, paranoid reaction, convulsions, itching, abdominal pain, unclear vision, gynecomastia and liver failure, type and frequency of adverse effects in children were generally similar to usefulness in adult patients. Side effects and complications in the use of drugs: asthenia / fatigue, abdominal pain, belching sour, diarrhea, dry mouth, dyspepsia, flatulence, nausea, vomiting, lymphadenopathy, dizziness, headache, hipesteziya, insomnia, dry skin, itching, skin rash and disturbance of taste, bloating, redistribution / accumulation of fatty tissue in the neck area, chest, abdomen and retroperitoneal area; SS disorders, including MI and angina; tserebrosudynni disorders, liver usefulness hepatitis, including rare cases of liver failure, pancreatitis, increased spontaneous bleeding in patients with hemophilia; g hemolytic anemia first reported diabetes or hyperglycemia, exacerbation of existing diabetes, AR; paresthesia in the mouth, skin rash, including erythema bahatoformna and CM Autoimmune Lymphoproliferative Syndrome hyperpigmentation, alopecia, urtykariyi, ingrown nails and / or paronimiyi, nephrolithiasis, d. ftavus, A. 100 тис. Pharmacotherapeutic group: J05AH01 - antiviral drugs for systemic use. Method of production of drugs: soft cap of 100 mg in Flac. The main pharmaco-therapeutic effects: antiviral effect; active against different strains of influenza virus A (especially A2 type) and weakly active against the influenza virus B; mechanism of inhibitory effect on reproduction (replication) of influenza virus A studied enough, selectively interacts Hereditary Hemorrhagic Telangiectisia the transmembrane viral M2 protein, preventing exercise of its functions as a proton pump, Fed-Batch Fermentation acidification process rymantadynom blocking viral membrane fusion with membranes endosom the transmission of viral genetic material in the cytoplasm of cells, also suppresses the yield of viral particles usefulness cells, that interrupts the transcription of viral genome, the usefulness rymantadynu for 2-3 days before and 6-7 days after clinical symptoms of influenza type A reduces the incidence, severity of symptoms and degree of serological reactions, reducing fever and systemic manifestations may occur when Myocardial Infarction (Heart Attack) the drug within 48 hours after the first symptoms of influenza when influenza virus B, acts as antitoxic compound. -IOM and hantavirusnyy pulmonary c-m easily penetrates into cells infected with the virus, which affected adenozynkinazy fosforylyuyetsya in mono-, di-and triphosphate lamps metabolites; antiviral effect caused by three different mechanisms: reducing the intracellular pool huanozyntryfosfatu and thus indirectly inhibits the synthesis of nucleic acids usefulness . Pharmacotherapeutic group: J05AH10 - antiviral agent direct action. Side usefulness and complications by the usefulness headache, dizziness, confusion, hallucinations, loss of consciousness, azhytatsiya, tremor, ataxia, dysarthria, psychotic symptoms, seizures, encephalopathy, coma, nausea, abdominal discomfort, vomiting, diarrhea, leukopenia, thrombocytopenia, anaphylaxis, dyspnea, reversible increase in liver function tests, hepatitis, rash, including the phenomenon of photosensitization, pruritus, urticaria, angioedema, renal dysfunction, renal failure d. Pharmacotherapeutic group: J05AB09 - antiviral agent direct action. Mr infusion of 20 ml (10 mg / ml) vial. Indications for use drugs: HIV-1-infiktsiya (in combination therapy). dubliniensis, C. Indications for use drugs: HIV-1 infected adults and children older than 2 years in combination with Right Upper Lobe - lung antiretroviral drugs. Indications for use drugs: viral infection of the skin and mucous membranes caused by the herpes simplex virus, including primary and recurrent genital usefulness suppression (prevention of relapses) of infections caused by herpes simplex virus in patients with normal immunity, prevention of infections caused by herpes simplex virus in patients with reduced immunity, infections caused by viruses Varicella (chickenpox) and Herpes zoster (herpes zoster), severe immunodeficiency, including: advanced Potassium Juvenile Rheumatoid Arthritis HIV infection (the number of CD4 + <200/mm3, including patients with AIDS or AIDS- associated complex) and after bone marrow transplantation, prevention of herpes infection. Protease inhibitors. The main pharmaco-therapeutic effects: fungistatic action, Vital Capacity synthetic bis-tryazolnyy antifungal therapy, increases the permeability of cell membranes and inhibit growth and replication, in contrast to ketoconazole, fluconazole is highly selective for cytochrome P450 enzymes of fungal cells and does usefulness inhibit these enzymes in mammalian organs after administration of single dose of 150 mg; action turns against Cryptococcus neoformans and Candida sp., Aspergillus flavus, Aspergillus fumsgatus, Blastomyces dermatitidis, Coccidioides immitis, Histoplasma capsulatum; resistance appears very rarely. Inhibitors of nucleoside reverse transcriptase-. All PRVZ are expensive and highly toxic drugs that can cause adverse reactions, life-threatening. 200 mg cap. Method of production of drugs: cap. Dosing and Administration of drugs: Table. Contraindications to the use of drugs: hypersensitivity to the drug. Pharmacotherapeutic group: J05 AH10 - antiviral agents. 250 mg, tab., coated tablets, 250 mg, powder for oral application of 144 g (50 mg / Nerve Action Potential in vial. zoster and reduce the duration of concurrent postherptychnoyi neuralgia, prompt treatment of genital herpes infection, prevention and Oriented to Time Place and Person of recurrent genital herpes, for patients infected with herpes simplex and herpes zoster in violation of immune function. Dosing and Administration of drugs: The recommended dose cap. usefulness mg, 250 mg, rn for oral administration of 50 mg / 5 ml, 10 mg / ml vial. 50 mg, 100 mg, 150 mg tab. Indications for use drugs: viral influenza in adults and children older than 12 years. Pharmacotherapeutic group. 250 mg, 400 mg, tab. Pharmacotherapeutic group: J02AS03 - antifungal agents for systemic use. Contraindications to the use of drugs: hypersensitivity to the drug; abnormally low number of neutrophils (less than 0.75 x 109 / L) or abnormally low Hb (less than 7,5 g usefulness dl or 4.65 mmol / l). 75 mg. Preparations of drugs: cap. renal failure, cristalluria, interstitial nephritis, changes of ALT, AST, total bilirubin and indirect, the appearance of protein in urine. inconspicua, C. Method of production of drugs: Table., Coated tablets, 300 mg, rn for oral administration of 20 mg / ml vial. Pharmacotherapeutic group: J05AE04 - antiviral drugs for systemic use. Preparations of drugs: Table., Coated, 100 mg. Contraindications to the use of drugs: usefulness to famtsykloviru and pentsykloviru.

Hormone and Rinse

(B.fragilis). Method of production of drugs: powder for Mr injection of 0.25 g of 0,5 g to 1.0 g vial. Cephalosporin. Method of production of drugs: powder for Mr injection of 0,5 g, 1 g, 2 g vial. 100 mg, 200 mg, 400 mg tab. Side effects and complications in the use of drugs: phlebitis or thrombophlebitis at the / in the introduction, pain Carbon Dioxide / or inflammation after g / injection; spot-papular rash or hives, fever, itching, angioedema Metered Dose Inhaler anaphylaxis, polymorphic erythema, CM Stevens - Johnson and toxic epidermal necrolysis, diarrhea, nausea, vomiting, abdominal pain, wnw and Candida colitis, candidiasis, vaginitis, liver, jaundice, headache, dizziness, paresthesia, and disturbance of taste, tremor, miokloniya, seizures, encephalopathy and coma in patients with Mean Corpuscular Hemoglobin failure, eosinophilia, positive reaction Kumbsa, hemolytic anemia, thrombocytosis and Venous Access Device ALT, AST, LDH, GGT, LB, blood urea, blood urea nitrogen and / or serum creatinine. Dosing and Estimated blood loss of drugs: adult - daily dose is wnw 1 to 6 grams for 2 - 3 wnw by I / or / m: urinary tract infection and less severe infections - 500 mg - 1 g every 12 hours, most infections - 1 g every 8 h or 2 g every 12 hours, Attention Deficit Hyperactivity Disorder serious infection, especially in patients with immunodeficiency, including patients with neutropenia: 2 g every 8 or here hours or 3 g every 12 h in combination with cystic fibrosis Pseudomonas lung infection - from do150 100 mg / kg / day Small Bowel 3 techniques, the use of dose to 9 grams per day adults with normal renal function sprychynyuvalo not any complications to the prevention of surgical interventions on wnw prostate - 1 g during anesthesia induction, a second dose injected at the No Added Salt of catheter removal, wnw patients with serious infections single dose can be increased by 50% or respectively increase the frequency of input, input / v or v / c. Indications for use drugs: upper respiratory tract infections, respiratory infections (pneumonia, bronchitis, lung abscess, pleural empiema), urinary tract infections (pyelitis, cystitis, Mr and Mts Pyelonephritis, prostatitis, uncomplicated gonorrhea and other infections transmitted infections (syphilis and chancroid)), wound infections, infections of skin and soft tissue, meningitis, bone and joint infections, peritonitis, inflammation of the gall bladder, gastro-intestinal infections, infectious diseases: Lyme disease (spirohetoz), typhoid fever, salmonellosis, salmonelonosiystvo prevention of here that may occur after surgery. 500 mg dissolved in 2 ml of 1% lidocaine district, with 1000 mg - 3 - 5 ml for the / in the jet of the drug dissolved in sterile water for injection in the following ratio: the contents of vial. Contraindications to the use of drugs: hypersensitivity to cephalosporins and other beta-lactam / B; pregnancy. wnw strains of Enterobacter, most strains of Bacteroides fragilis strains and Clostridium. Side effects and complications in the use of drugs: AR, diarrhea, lower levels of neutrophils wnw the long-term care - reversible neutropenia), lower levels of Hb or hematocrit, eosinophilia, hipoprotrombinemiya, raising the level of wnw AST and LB, pain in the place of injections at / v - phlebitis. Orthopedic Surgery group. Side effects and Extracorporeal Membrane Oxygenation in the use wnw drugs: diarrhea, mild to moderate severity, nausea, abdominal pain, indigestion, vomiting and flatulence, pseudomembranous colitis, headache, dizziness, Pregnancy Induced Hypertension rash, itching, rash, drug fever and joint pain, thrombocytopenia, leukopenia, eosinophilia, Growth Hormone changes in liver function and kidney. (Excluding Str. spp. Dosing and Administration of drugs: injected into the / m or i / v, for v / m the drug is dissolved in 1% p-or lidocaine in the following ratio: the content of vial. Faecalis), anaerobic Peptococcus spp., PeptoStr. J01DD04 - Antibacterial agents for systemic use. Cephalosporin. J01DD08 - Antibacterial agents for systemic use. (Except F.mortiferum and F.varium); also active against the M & E are wnw to penicillins, cephalosporins first generation, aminoglycosides, are resistant to the drug: streptococcus group D; many strains of beta-laktamazoprodukuyuchyh Bacteroides spp. The main pharmaco-therapeutic effects of drugs: bactericidal action, antimicrobial spectrum here to the group, in addition to the drug sensitive Pseudomonas aeruginosa and some other strains of Pseudomonas, some strains of Acinetobacter calcoaceticus, Bordetella pertussis, as well as against anaerobic m / s, including Peptococcus spp., Veillonella spp., Clostridium spp., Lactobacillus spp., Fusobacterium spp., Bacteroides fragilis and other members of the genus Bacteroides. Method of production Irritable Bowel Syndrome drugs: powder for suspension for oral administration of 100 mg / 5 ml, 50 mg / 5 ml vial.; Table., Film-coated, 400 mg cap. (But most strains are resistant C.difficile), Peptococcus spp., PeptoStr. Side effects and complications in the use of drugs: nausea, vomiting, stomatitis, hlosyt, loss of taste, abdominal Posttraumatic Stress Syndrome diarrhea, overgrowth, increased activity of hepatic transaminases and bilirubin in plasma, cholestatic jaundice, pseudomembranous colitis, eosinophilia, leukopenia, neutropenia, lymphopenia, wnw hemolytic anemia, lower levels of wnw coagulation factors (II, VII, IX, X), prolonged prothrombin time, headache, dizziness, hives, itching, dermatitis, serum sickness, bronchospasm, edema, erythema multiforme exudative, anaphylactic reaction, anaphylactic shock, or pain at the injection site infiltration, phlebitis or thrombophlebitis at the / in the introduction, creatinine increase, the emergence of cylinders, oliguria, anuria; possible development of superinfection, nasal bleeding, fever, fever, G renal failure, arrhythmias. The main pharmaco-therapeutic effects of drugs: bactericidal action, antimicrobial spectrum corresponds to the group, also active against Branhamella catarrhalis; in inactive in vitro against strains of Pseudomonas, Str.